Effects of alpha-MSH on corneal epithelial lesions in rats

Josip Pavan1, Adrian Lukenda, Nikola Stambuk

  • 1University of Zagreb, Dubrava University Hospital, Department of Ophthalmology, Zagreb, Croatia. josip.pavan@g.htnet.hr

Collegium Antropologicum
|February 9, 2013
PubMed

Insights

Alpha-melanocyte stimulating hormone (alpha-MSH) effectively promotes corneal epithelial healing in rats. This hormone also reduces ocular irritation, offering a potential alternative to corticosteroid treatments for eye injuries.

Area of Science:

  • Ophthalmology
  • Wound Healing
  • Pharmacology

Background:

  • Corneal epithelial defects are common ocular injuries.
  • Current treatments may have side effects.
  • Alpha-melanocyte stimulating hormone (alpha-MSH) has shown anti-inflammatory properties.

Purpose of the Study:

  • To investigate the effect of alpha-MSH on corneal epithelial wound healing.
  • To assess the impact of alpha-MSH on ocular irritation.
  • To compare alpha-MSH efficacy with a saline control.

Main Methods:

  • Corneal epithelial lesions were induced in male Wistar rats.
  • Lesions were treated with topical alpha-MSH (1 x 10(-4) mg/mL) or 0.9% NaCl.
  • Healing and ocular irritation were monitored.

Main Results:

  • Alpha-MSH significantly accelerated corneal epithelial healing compared to the control.
  • A significant reduction in ocular irritation was observed with alpha-MSH treatment.
  • No major side effects were noted with topical alpha-MSH.

Conclusions:

  • Topical alpha-MSH promotes corneal wound healing.
  • Alpha-MSH reduces local inflammatory responses in the eye.
  • Alpha-MSH represents a promising therapeutic agent for corneal injuries, potentially avoiding corticosteroid side effects.

Related Concept Videos